Evidence map›Paper›PMID 23738047›Full record

ReviewOxidative medicine and cellular longevity2013

Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants.

Borut Poljsak, Dušan Šuput, Irina Milisav

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05936528 (The Effect of Lactoferrin in Improving Clinical Outcomes in ICU Patients), which is not on this map. Cited by 494 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
494citing papers in PubMed, 4 pooled it
27.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05936528 phase4completednot on this mapstarted 2025, after this paper: background citation

The Effect of Lactoferrin in Improving Clinical Outcomes in ICU Patients

TypeinterventionalSponsorMansoura University HospitalRan2025 to 2026Enrolled660ConditionsCritical IllnessArmsLactoferrin, Antioxidant therapies, Dexamethasone, Antibacterial therapies
3 · Its place in the literature

Who cites it

494 citing papers in PubMed, 4 syntheses or guidelines pooled it, 1,331 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

434 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Borut PoljsakUniversity of Ljubljana, Laboratory of Oxidative Stress Research, Faculty of Health Sciences, Zdravstvena Pot 5, SI-1000 Ljubljana, Slovenia.
Dušan Šuput
Irina Milisav
University of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Free radical damage is linked to formation of many degenerative diseases, including cancer, cardiovascular disease, cataracts, and aging. Excessive reactive oxygen species (ROS) formation can induce oxidative stress, leading to cell damage that can culminate in cell death. Therefore, cells have antioxidant networks to scavenge excessively produced ROS. The balance between the production and scavenging of ROS leads to homeostasis in general; however, the balance is somehow shifted towards the formation of free radicals, which results in accumulated cell damage in time. Antioxidants can attenuate the damaging effects of ROS in vitro and delay many events that contribute to cellular aging. The use of multivitamin/mineral supplements (MVMs) has grown rapidly over the past decades. Some recent studies demonstrated no effect of antioxidant therapy; sometimes the intake of antioxidants even increased mortality. Oxidative stress is damaging and beneficial for the organism, as some ROS are signaling molecules in cellular signaling pathways. Lowering the levels of oxidative stress by antioxidant supplements is not beneficial in such cases. The balance between ROS and antioxidants is optimal, as both extremes, oxidative and antioxidative stress, are damaging. Therefore, there is a need for accurate determination of individual's oxidative stress levels before prescribing the supplement antioxidants.

Indexed as

AnimalsAntioxidantsHumansModels, BiologicalOxidation-ReductionOxidative StressReactive Oxygen SpeciesSignal TransductionAntioxidantsReactive Oxygen Species

Identifiers

PMID23738047
PMCPMC3657405
OpenAlexW2019227799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.